导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 26.96% | 143/1050 |
| 近一周 | -2.81% | 738/1104 |
| 近一月 | -4.30% | 539/1102 |
| 近一季 | -0.23% | 263/1092 |
| 近半年 | 27.97% | 84/1070 |
| 近一年 | 12.57% | 321/1018 |
| 近两年 | 110.86% | 159/926 |
| 近三年 | 51.24% | 246/834 |
| 成立以来 | 100.20% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.29% 876/1070 |
81.70% 101/1101 |
- - |
- - |
| 2025 | 14.14% 771/1065 |
8.94% 186/1014 |
-1.25% 793/1038 |
24.29% 462/1050 |
-14.64% 977/1065 |
| 2024 | 5.55% 409/1011 |
-2.81% 467/960 |
-13.88% 932/983 |
16.26% 163/991 |
8.47% 79/1011 |
| 2023 | 14.10% 12/952 |
32.63% 8/880 |
10.89% 16/895 |
-18.20% 837/915 |
-5.15% 525/952 |
| 2022 | -25.75% 521/867 |
-21.60% 614/773 |
3.35% 614/806 |
-9.80% 233/845 |
1.59% 353/867 |
| 2021 | 14.54% 195/740 |
-7.24% 427/580 |
24.92% 94/659 |
-3.75% 307/704 |
2.70% 320/740 |
| 2020 | 29.39% 351/554 |
-7.05% 339/419 |
22.66% 234/466 |
-0.20% 422/517 |
13.70% 233/554 |
| 2019 | 60.72% 77/410 |
33.01% 215/1149 |
-5.80% 763/1231 |
13.75% 60/390 |
12.76% 97/410 |
| 2018 | -24.34% 134/349 |
- - |
- - |
- - |
-9.98% 291/1080 |
| 2017 | 10.70% 130/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 嘉实文体娱乐股票A VS. 东吴新产业精选股票A(580008) |